| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |